Dentsply Sirona (XRAY) Cash & Equivalents (2009 - 2026)

Dentsply Sirona's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $190.0 million for Q1 2026.

• Quarterly Cash & Equivalents fell 52.26% year-over-year to $190.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $190.0 million (down 52.26% YoY) and the FY2025 annual result came in at $326.0 million, up 19.85% from the prior year.
• Cash & Equivalents was $190.0 million for Q1 2026 at Dentsply Sirona, down from $326.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $418.0 million in Q3 2022 and bottomed at $190.0 million in Q1 2026.
• A 5-year average of $326.4 million and a median of $326.0 million in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 48.75% — and 2026, when it tumbled 52.26%.
• Dentsply Sirona's Cash & Equivalents stood at $365.0 million in 2022, then dropped by 8.49% to $334.0 million in 2023, then dropped by 18.56% to $272.0 million in 2024, then advanced by 19.85% to $326.0 million in 2025, then slumped by 41.72% to $190.0 million in 2026.
• Business Quant data shows XRAY's Cash & Equivalents at $190.0 million in Q1 2026, $326.0 million in Q4 2025, and $363.0 million in Q3 2025.